|1.||Huemer, Georg M: 2 articles (07/2009 - 03/2003)|
|2.||Sándor, Viktor: 1 article (12/2014)|
|3.||Kemény, Agnes: 1 article (12/2014)|
|4.||Horváth, Katalin: 1 article (12/2014)|
|5.||Pintér, Erika: 1 article (12/2014)|
|6.||Helyes, Zsuzsanna: 1 article (12/2014)|
|7.||Boros, Melinda: 1 article (12/2014)|
|8.||Kilár, Ferenc: 1 article (12/2014)|
|9.||Bagoly, Teréz: 1 article (12/2014)|
|10.||Szolcsányi, János: 1 article (12/2014)|
03/01/2003 - "The topical combination of nonivamide and nicoboxil was effective in reducing ischemic necrosis in failing random-pattern skin flaps in this rat model. "
07/01/2009 - "Although not as effective as the surgical delay procedure, the topical combination of nicoboxil and nonivamide proved to be of significant value in order to ameliorate ischemic necrosis in experimental skin flaps. "
03/01/2003 - "The topically applied combination of nonivamide and nicoboxil resulted in a statistically significant decrease in skin flap necrosis, compared with the control group (mean percentage of skin flap necrosis in the nonivamide/nicoboxil-treated group, 22.6 +/- 6.0 percent; control group, 36.8 +/- 4.3 percent; p< 0.05). "
03/01/2003 - "The effects of a topically applied combination of nonivamide and nicoboxil in improving skin perfusion and preventing distal flap necrosis were tested in a random-pattern dorsal skin flap model. "
09/01/1999 - "Therefore, the aim of the present study was to investigate the influence of the type of preparation on the time course of action of the capsaicinoid nonivamide monitored by the axon-reflex-induced hyperemic action and area of erythema. "
08/14/2001 - "The present study indicates that there is a moderate correlation between in vitro skin permeation and in vivo erythema responses of topically applied capsaicin and nonivamide. "
08/14/2001 - "Nonivamide-treated skin showed stronger erythema than capsaicin-treated skin. "
08/14/2001 - "Both skin stripping technique and Mexameter were applied to evaluate the level of capsaicin and nonivamide retained in stratum corneum (SC) and skin erythema in vivo. "
06/01/2014 - "Addition of 0.15 mg nonivamide to a glucose solution reduced ad libitum energy intake from a standardized breakfast in moderately overweight men."
06/01/2014 - "Since bolus administration of capsaicin has been shown to reduce appetite and ad libitum energy intake, this study elucidated the satiating effect of the less pungent capsaicin analog, nonivamide, on subjective feelings of hunger, ad libitum food intake, and satiating hormones in moderately overweight male subjects. "
06/01/2014 - "The capsaicin analog nonivamide decreases total energy intake from a standardized breakfast and enhances plasma serotonin levels in moderately overweight men after administered in an oral glucose tolerance test: a randomized, crossover trial."
12/01/2014 - "In the clinical study the 21 day local nonivamide treatment reduced the pain sensation. "
12/01/2014 - "We conclude that nonivamide treatment exerts analgesic action in chronic low back pain and causes the release of the antinociceptive and anti-inflammatory neuropeptide somatostatin which may play pivotal role in the pain-relieving effect. "
01/01/1994 - "Intravenous (i.v.) injection (10 micrograms/kg) of nonivamide produced triphasic pressure responses (A; depressor, B; pressor, and C; depressor) and biphasic bradycardia responses (f; fast bradycardia and s; slow bradycardia). "
04/01/1991 - "Intravenous injection of nonivamide or nonivamide succinate (25, 250 nmol/kg) into Wistar rats induced bradycardia, hypotension, apnea and a triphasic blood pressure response: an initial short fall (effect A), an intermediate rise (effect B), and a subsequent delayed fall (effect C) of blood pressure. "
09/01/1999 - "Nitrated nonivamide (NVANO)-induced triad hypotension, and biphasic bradycardia at 0.25-1.0 mg/kg (IV) was inhibited by capsazepine (1.0 mg/kg, IV), atropine (1.0 mg/kg, IV), and vagotomy in rats. "
|3.||Serotonin (5 Hydroxytryptamine)
|6.||Succinic Acid (Succinate)
|7.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|10.||N- (4- hydroxy- 5- nitro- 3- methoxybenzyl)nonanamide